Success Metrics

Completion Rate
0%(0/1)
Active Trials
3(38%)
Terminated
1(13%)

Phase Distribution

Ph phase_2
2
25%
Ph not_applicable
6
75%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Terminated(1)
Other(3)

Detailed Status

Active, not recruiting3
unknown3
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (25.0%)
N/A6 (75.0%)

Trials by Status

not_yet_recruiting113%
active_not_recruiting338%
terminated113%
unknown338%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
RADIATION
Total Trials
8